Immunovant, Inc. (IMVT) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2026 | $-2.77 | -1.5% |
| 2025 | $-2.73 | -45.2% |
| 2024 | $-1.88 | -9.9% |
| 2023 | $-1.71 | -19.6% |
| 2022 | $-1.43 | -17.2% |
| 2021 | $-1.22 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2026 | $-2.77 | -1.5% |
| 2025 | $-2.73 | -45.2% |
| 2024 | $-1.88 | -9.9% |
| 2023 | $-1.71 | -19.6% |
| 2022 | $-1.43 | -17.2% |
| 2021 | $-1.22 | — |